NanoString Technologies (License of nCounter Diagnostic Assets and Rights) is Buildings and Property in United States that focus on license business. They cover business area such as license, gene activity, asset, right.
-
License
-
530 Fairview Avenue North
Seattle, WA 98109
United States
Private
licensegene activityassetright
* We use standard office opening hours in near NanoString Technologies (License of nCounter Diagnostic Assets and Rights)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NanoString Technologies (License Of NCounter Diagnostic Assets And Rights) is Buildings and Property business from United States that founded in - ( years old in ), NanoString Technologies (License of nCounter Diagnostic Assets and Rights) business is focusing on License.
NanoString Technologies (License of nCounter Diagnostic Assets and Rights) headquarter office and corporate office address is located in 530 Fairview Avenue North Seattle, WA 98109 United States.
NanoString Technologies (License of nCounter Diagnostic Assets and Rights) was founded in United States.
In , NanoString Technologies (License of nCounter Diagnostic Assets and Rights) is currently focus on license sector.
Above is snippet of Google Trends for "license" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NanoString Technologies (License of nCounter Diagnostic Assets and Rights), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
